Skip to Content
MilliporeSigma
  • Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis.

Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis.

Analytical and bioanalytical chemistry (2014-05-13)
Weidong Dai, Peiyuan Yin, Ping Chen, Hongwei Kong, Ping Luo, Zhiliang Xu, Xin Lu, Guowang Xu
ABSTRACT

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Discovery of novel biomarkers for early HCC from other liver diseases such as cirrhosis is of great clinical benefit. In this study, a novel steroid hormone metabolomic method based on liquid chromatography-mass spectrometry combined with logistic regression analysis was applied to study the steroid hormone disorders and to screen potential urinary steroid hormone biomarkers of early HCC. Thirty-six urinary steroid hormones were detected and quantified in healthy controls, cirrhotic patients, and early HCC patients. Heat map analysis and multivariate statistical analysis suggested severe disorders of steroid hormone network and holistically decreased urinary steroid hormone pattern in cirrhotic and early HCC patients. Logistic regression analysis reveals that a panel of two urinary steroid hormones (epitestosterone and allotetrahydrocortisol) displayed excellent diagnostic capability for distinguishing early HCC from cirrhosis with area under the curve (AUC) = 0.938 of receiver operating characteristic (ROC) analysis. These results help to overcome the disadvantage of lower sensitivity and specificity of alpha-fetoprotein for distinguishing early HCC from cirrhosis. Our work shows that steroid hormone metabolomics is a promising biomarker tool for biomarker study of early HCC.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Acetonitrile solution, contains 10.0% acetone, 0.05% formic acid, 40.0% 2-propanol
Sigma-Aldrich
Acetonitrile solution, contains 0.05 % (w/v) ammonium formate, 5 % (v/v) water, 0.1 % (v/v) formic acid, suitable for HPLC
Sigma-Aldrich
Methanol, SAJ special grade
Sigma-Aldrich
L-Ascorbic acid, FCC, FG
Sigma-Aldrich
Methanol, NMR reference standard
Sigma-Aldrich
Methanol, JIS special grade, ≥99.8%
Sigma-Aldrich
4-(Dimethylamino)benzaldehyde, JIS special grade, ≥99.0%
Sigma-Aldrich
Methanol, SAJ first grade, ≥99.5%
USP
Valacyclovir Related Compound G, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Methanol, HPLC Plus, ≥99.9%, poly-coated bottles
Sigma-Aldrich
Methanol, suitable for HPLC
Sigma-Aldrich
Methanol, suitable for HPLC, gradient grade, 99.93%
Sigma-Aldrich
Acetonitrile solution, contains 0.1 % (v/v) formic acid, suitable for HPLC
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
4-(Dimethylamino)benzoic acid, 98%
Sigma-Aldrich
4-(Dimethylamino)benzaldehyde, ACS reagent, 99%
Sigma-Aldrich
Acetonitrile solution, contains 0.05 % (v/v) trifluoroacetic acid
Sigma-Aldrich
4-(Dimethylamino)benzaldehyde, 98%
Sigma-Aldrich
Acetonitrile solution, contains 0.1 % (v/v) trifluoroacetic acid, suitable for HPLC
Supelco
L-Ascorbic acid, analytical standard
Sigma-Aldrich
L-Ascorbic acid, 99%
Sigma-Aldrich
L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Supelco
Methanol, analytical standard
Sigma-Aldrich
L-Ascorbic acid, BioUltra, ≥99.5% (RT)
Supelco
4-(Dimethylamino)benzaldehyde solution, 10 g/L in isopropanol, for TLC derivatization
Sigma-Aldrich
L-Ascorbic acid, puriss. p.a., ≥99.0% (RT)
Sigma-Aldrich
L-Ascorbic acid, ACS reagent, ≥99%
Sigma-Aldrich
L-Ascorbic acid, tested according to Ph. Eur.
Sigma-Aldrich
4-(Dimethylamino)benzaldehyde, puriss. p.a., reag. Ph. Eur., ≥99% (perchloric acid titration)
Sigma-Aldrich
L-Ascorbic acid, reagent grade